ISSCR News
ISSCR Joins Coalition Letter to Support 5% Increase in NIH Funding for FY 2024
The ISSCR is among 373 members of the Ad Hoc Group for Medical Research who signed a joint letter in support robust funding for the National Institutes of Health (NIH). For fiscal year (FY) 2024, the Ad Hoc Group recommends at least $50.924 billion for NIH’s foundational work, a $3.465 billion increase over the comparable FY 2023 program level.
ISSCR Offers Recommendations on Risk Mitigation in Advancing Stem Cell Therapies
On 13 December 2022, ISSCR hosted its annual Liaison Meeting with the U.S. Food and Drug Administration. FDA professionals gathered virtually with ISSCR leaders to discuss advances in the development of stem cell therapies.
ISSCR Shares Concerns Regarding New Google Ads Policy
…the ISSCR is concerned that unscrupulous clinics may misuse the update to Google’s policy by promoting unproven therapies under the guise of distributing material that is “exclusively educational or informational in nature.” If so, this would harm consumers and public health.
The ISSCR Endorses the Ad Hoc Group for Medical Research’s FY 2023 Recommendations
To promote the sustained, robust growth necessary to make consequential progress against pressing health challenges, in fiscal year (FY) 2023, the Ad Hoc Group recommends a program level of at least $49.048 billion for the NIH base budget, which would represent an increase of $4.1 billion over the comparable FY 2022 funding level (an increase of $3.5 billion or 7.9% in the NIH appropriation plus funding from the 21st Century Cures Act for specific initiatives).
The ISSCR Comments on Draft Guidance from FDA - Real-World Data: Assessing Registries to Support Regulatory Decision-Making for Drug and Biological Products
The ISSCR shared comments on draft guidance from the FDA's Center for Biologics Evaluation and Research (CBER) (Docket No. FDA2021-D-1146) Real-World Data: Assessing Registries to Support Regulatory Decision Making for Drug and Biological Products.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .